Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews · Hepato-Biliary

No studies found 4 · 66.7%GRADE not reported 0 · 0%Very low 2 · 33.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

All‐cause mortality at 5 years · people with resectable cholangiocarcinoma

It is very uncertain whether adjuvant chemotherapy changes all‐cause mortality at 5 years compared with no chemotherapy (very low certainty).

1 finding from 1 review

Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma 2021 · Cochrane Headline outcomes only
RR 0.92 [0.84, 1.01]
4 studies · 867 participants
Very low

Serious adverse events · people with resectable cholangiocarcinoma

It is very uncertain whether adjuvant chemotherapy changes serious adverse events compared with no chemotherapy (very low certainty).

1 finding from 1 review

Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma 2021 · Cochrane Headline outcomes only
RR 17.82 [2.43, 130.82]
1 study · 219 participants
Very low

Health‐related quality of life · people with resectable cholangiocarcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cancer‐related mortality at maximal · people with resectable cholangiocarcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Time to recurrence · people with resectable cholangiocarcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Non‐serious adverse events · people with resectable cholangiocarcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found